Effect of age, menopause and cyclophosphamide use on damage accrual in systemic lupus erythematosus patients from LUMINA, a multiethnic US cohort (LUMINA LXIII).
González
L A
LA
Pons-Estel
G J
GJ
Zhang
J S
JS
McGwin
G
G
Roseman
J
J
Reveille
J D
JD
Vilá
L M
LM
Alarcón
G S
GS
D000328:Adult; D001741:Black or African American; D000367:Age Factors; D015331:Cohort Studies; D003520:Cyclophosphamide / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000473:pathology; D008593:Menopause; D017058:Mexican Americans; D008875:Middle Aged; D016649:Primary Ovarian Insufficiency; D012307:Risk Factors; D012720:Severity of Illness Index; D014481:United States; D044465:White People
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide